KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) EBIT Margin (2020 - 2025)

Organon has reported EBIT Margin over the past 6 years, most recently at 13.93% for Q4 2025.

  • Quarterly results put EBIT Margin at 13.93% for Q4 2025, down 416.0% from a year ago — trailing twelve months through Dec 2025 was 18.19% (up 795.0% YoY), and the annual figure for FY2025 was 18.19%, up 1556.0%.
  • EBIT Margin for Q4 2025 was 13.93% at Organon, down from 22.35% in the prior quarter.
  • Over the last five years, EBIT Margin for OGN hit a ceiling of 25.98% in Q3 2024 and a floor of 36.23% in Q4 2023.
  • Median EBIT Margin over the past 5 years was 11.45% (2021), compared with a mean of 6.7%.
  • Biggest five-year swings in EBIT Margin: crashed -2542bps in 2021 and later surged 6100bps in 2024.
  • Organon's EBIT Margin stood at 22.65% in 2021, then tumbled by -44bps to 32.53% in 2022, then decreased by -11bps to 36.23% in 2023, then soared by 150bps to 18.09% in 2024, then fell by -23bps to 13.93% in 2025.
  • The last three reported values for EBIT Margin were 13.93% (Q4 2025), 22.35% (Q3 2025), and 20.33% (Q2 2025) per Business Quant data.